Singapore: Oncoshot, which leverages AI technology to address the inefficiencies of cancer clinical trials, has announced a pre-series A funding round led by MassMutual Ventures (MMV). Other investors for this stage come from a suite of healthtech veterans that include Milltrust International and health industry angel investors. Funding will support Oncoshot’s further expansion into Australia and India where, including…
Home Healthcare Markets International Business Funding round-up: Medical Microinstruments, Wysa, Mosanna Therapeutics, ForSight Robotics, Oncoshot